Ranbaxy taking 'stringent steps' to end US FDA ban

Ranbaxy taking 'stringent steps' to end US FDA ban

NEW DELHI (AFP) – India's biggest drugmaker by sales, Ranbaxy Laboratories, has assured shareholders it is taking "stringent steps" to resolve a US ban on imports of medicines manufactured at its newly renovated showcase plant. The US Food and Drug 

3
Like
Save

Comments

Write a comment

*